Mallinckrodt Plc on Tuesday said it had agreed to a $1.6 billion settlement proposal in which its generic drug business would file for bankruptcy in order to resolve thousands of lawsuits alleging it helped fuel the U.S. opioid epidemic.
Powered by WPeMatico